Company Description

TAO Synergies Inc. owns and operates an AI token. The company executes a cryptocurrency treasury strategy centered on the acquisition and staking of the TAO token, the native utility token of the Bittensor network.

TAO Synergies Inc. was formerly known as Synaptogenix, Inc. and changed its name to TAO Synergies Inc. in June 2025.

The company was incorporated in 2012 and is headquartered in New York, New York.

TAO Synergies Inc.

Country	United States
Founded	2012
Industry	Software - Infrastructure
Sector	Technology
Employees	4

Contact Details

Address: 1185 Avenue of the Americas, 3rd Floor New York, New York 10036 United States
Phone	973 242 0005
Website	taosynergies.com

Stock Details

Ticker Symbol	TAOX
Exchange	NASDAQ
Stock Type	Common Stock
Fiscal Year	January - December
Reporting Currency	USD
CIK Code	0001571934
ISIN Number	US87167T3005
Employer ID	46-1585656
SIC Code	6199

Key Executives

Name	Position
Joshua N. Silverman	Executive Chairman of the Board
Dr. Daniel L. Alkon M.D.	President and Director
Robert Weinstein	Chief Financial Officer, Executive Vice President, Treasurer and Secretary
Dr. Alan J. Tuchman M.D., MBA(FAAN)	Chief Medical Officer

Latest SEC Filings

Date	Type	Title
Nov 21, 2025	EFFECT	Notice of Effectiveness
Nov 17, 2025	DEF 14A	Other definitive proxy statements
Nov 17, 2025	ARS	Filing
Nov 14, 2025	10-Q	Quarterly Report
Nov 12, 2025	S-3	Registration statement under Securities Act of 1933
Nov 7, 2025	PRE 14A	Other preliminary proxy statements
Oct 24, 2025	D	Notice of Exempt Offering of Securities
Oct 14, 2025	8-K	Current Report
Aug 29, 2025	8-K	Current Report
Aug 14, 2025	S-8	Securities to be offered to employees in employee benefit plans

View All SEC Filings